Novel Agonist Anti-GPCR Antibody to Trigger Resolution of Inflammation
- First-in-class antibody targeting GPCR with agonistic activity
- Anti-GPCR antibody to trigger resolution of inflammation and treat chronic inflammatory diseases
- Agonist Antibodies inhibit inflammatory immune cell recruitment and activation